Kura Oncology, Inc. Business Operations Contracts & Agreements
13 Contracts & Agreements
- Collaboration Agreements (1 contract)
- Indemnification Agreements (1)
- Management Agreements (4)
- Sales Agreements (5)
- Services Agreements (2)
- Sales Agreement, dated November 2, 2023, by and among the Registrant, Leerink Partners LLC and Cantor Fitzgerald & Co (Filed With SEC on November 2, 2023)
- Master Collaboration Agreement, dated January 4, 2021 by and between the Registrant and Illumina, Inc (Filed With SEC on February 24, 2021)
- Management Services Agreement, effective as of October 1, 2014, by and between the Registrant and Araxes Pharma LLC (Filed With SEC on February 24, 2021)
- Services Agreement, effective as of October 1, 2014, by and between the Registrant and Wellspring Biosciences, Inc (Filed With SEC on February 24, 2021)
- Sales Agreement, dated March 5, 2019, by and among Kura Oncology, Inc., SVB Leerink LLC and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on March 5, 2019)
- Second Amendment to Management Services Agreement, effective as of April 1, 2018, by and between the Registrant and Araxes Pharma LLC (Filed With SEC on May 8, 2018)
- Amended and Restated Sales Agreement, dated March 12, 2018, by and between Kura Oncology, Inc. and Cowen and Company, LLC (Filed With SEC on March 12, 2018)
- Sales Agreement, dated January 27, 2017, by and between Kura Oncology, Inc. and Cowen and Company, LLC, as amended on November 9, 2017 (Filed With SEC on November 9, 2017)
- KURA ONCOLOGY, INC. $25,000,000 COMMONSTOCK SALES AGREEMENT (Filed With SEC on January 27, 2017)
- FIRST AMENDMENT TO MANAGEMENT SERVICES AGREEMENT (Filed With SEC on August 10, 2016)
- MANAGEMENTSERVICES AGREEMENT (Filed With SEC on June 2, 2015)
- SERVICESAGREEMENT (Filed With SEC on June 2, 2015)
- INDEMNIFICATION AGREEMENT (Filed With SEC on March 12, 2015)
